Annual EPS
-$5.51
+$8.61+60.98%
June 30, 2024
Summary
- As of February 7, 2025, BNTC annual earnings per share is -$5.51, with the most recent change of +$8.61 (+60.98%) on June 30, 2024.
- During the last 3 years, BNTC annual EPS has risen by +$49.40 (+89.97%).
- BNTC annual EPS is now -110.63% below its all-time high of $51.85, reached on June 30, 2019.
Performance
BNTC EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.48
+$0.05+9.31%
September 30, 2024
Summary
- As of February 7, 2025, BNTC quarterly earnings per share is -$0.48, with the most recent change of +$0.05 (+9.31%) on September 30, 2024.
- Over the past year, BNTC quarterly EPS has increased by +$2.16 (+81.82%).
- BNTC quarterly EPS is now -103.09% below its all-time high of $15.56, reached on September 30, 2016.
Performance
BNTC Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$5.29
+$2.57+32.70%
September 30, 2024
Summary
- As of February 7, 2025, BNTC TTM earnings per share is -$5.29, with the most recent change of +$2.57 (+32.70%) on September 30, 2024.
- Over the past year, BNTC TTM EPS has increased by +$5.72 (+51.96%).
- BNTC TTM EPS is now -168.88% below its all-time high of $7.68, reached on June 30, 2017.
Performance
BNTC TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
BNTC EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.0% | +81.8% | +52.0% |
| 3 y3 years | +90.0% | +81.8% | +52.0% |
| 5 y5 years | -110.6% | +81.8% | +52.0% |
BNTC EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.0% | at high | +95.4% | at high | +87.7% |
| 5 y | 5-year | -110.6% | +96.0% | at high | +99.0% | at high | +96.6% |
| alltime | all time | -110.6% | +99.7% | -103.1% | +99.8% | -168.9% | +98.0% |
Benitec Biopharma EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.48(-9.3%) | -$5.29(-32.7%) |
| Jun 2024 | -$5.51(-61.0%) | -$0.53(-67.7%) | -$7.86(-21.2%) |
| Mar 2024 | - | -$1.64(-37.9%) | -$9.98(-9.4%) |
| Dec 2023 | - | -$2.64(-13.4%) | -$11.01(-6.0%) |
| Sep 2023 | - | -$3.05(+15.1%) | -$11.71(-29.6%) |
| Jun 2023 | -$14.12(-62.7%) | -$2.65(-0.7%) | -$16.64(-32.1%) |
| Mar 2023 | - | -$2.67(-20.1%) | -$24.50(-14.4%) |
| Dec 2022 | - | -$3.34(-58.1%) | -$28.63(-18.9%) |
| Sep 2022 | - | -$7.98(-24.1%) | -$35.32(-6.8%) |
| Jun 2022 | -$37.88(-31.0%) | -$10.51(+54.6%) | -$37.88(+6.1%) |
| Mar 2022 | - | -$6.80(-32.2%) | -$35.70(-16.7%) |
| Dec 2021 | - | -$10.03(-4.8%) | -$42.84(-6.3%) |
| Sep 2021 | - | -$10.54(+26.6%) | -$45.73(-40.5%) |
| Jun 2021 | -$54.91(-60.1%) | -$8.33(-40.3%) | -$76.84(-33.2%) |
| Mar 2021 | - | -$13.94(+7.9%) | -$115.09(-14.4%) |
| Dec 2020 | - | -$12.92(-69.0%) | -$134.47(-13.6%) |
| Sep 2020 | - | -$41.65(-10.6%) | -$155.55(+13.8%) |
| Jun 2020 | -$137.70 | -$46.58(+39.8%) | -$136.68(+51.7%) |
| Mar 2020 | - | -$33.32(-2.0%) | -$90.10(+58.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | -$34.00(+49.3%) | -$56.78(+149.3%) |
| Sep 2019 | - | -$22.78(-46.8%) | -$22.78(-78.3%) |
| Jun 2019 | $51.85(-125.0%) | - | - |
| Jun 2018 | -$207.18(+63.2%) | -$42.80(+1313.7%) | -$105.17(+61.1%) |
| Mar 2018 | - | -$3.03(-9.0%) | -$65.28(+4.2%) |
| Dec 2017 | - | -$3.33(-94.1%) | -$62.62(-2.0%) |
| Sep 2017 | - | -$56.02(+1827.1%) | -$63.90(-932.1%) |
| Jun 2017 | -$126.98(-80.9%) | -$2.91(+690.1%) | $7.68(+338.4%) |
| Mar 2017 | - | -$0.37(-92.0%) | $1.75(-159.0%) |
| Dec 2016 | - | -$4.61(-129.6%) | -$2.97(-69.9%) |
| Sep 2016 | - | $15.56(-276.1%) | -$9.87(-96.2%) |
| Jun 2016 | -$663.07(+70.2%) | -$8.83(+73.6%) | -$261.05(-0.6%) |
| Mar 2016 | - | -$5.09(-55.8%) | -$262.62(+1.3%) |
| Dec 2015 | - | -$11.50(-95.1%) | -$259.29(+4.6%) |
| Sep 2015 | - | -$235.62(+2164.8%) | -$247.78(+1937.2%) |
| Jun 2015 | -$389.61(-79.6%) | -$10.40(+491.2%) | -$12.16(+591.2%) |
| Mar 2015 | - | -$1.76 | -$1.76 |
| Jun 2014 | -$1912.97(+32.1%) | - | - |
| Jun 2013 | -$1448.41 | - | - |
FAQ
- What is Benitec Biopharma annual earnings per share?
- What is the all time high annual EPS for Benitec Biopharma?
- What is Benitec Biopharma annual EPS year-on-year change?
- What is Benitec Biopharma quarterly earnings per share?
- What is the all time high quarterly EPS for Benitec Biopharma?
- What is Benitec Biopharma quarterly EPS year-on-year change?
- What is Benitec Biopharma TTM earnings per share?
- What is the all time high TTM EPS for Benitec Biopharma?
- What is Benitec Biopharma TTM EPS year-on-year change?
What is Benitec Biopharma annual earnings per share?
The current annual EPS of BNTC is -$5.51
What is the all time high annual EPS for Benitec Biopharma?
Benitec Biopharma all-time high annual earnings per share is $51.85
What is Benitec Biopharma annual EPS year-on-year change?
Over the past year, BNTC annual earnings per share has changed by +$8.61 (+60.98%)
What is Benitec Biopharma quarterly earnings per share?
The current quarterly EPS of BNTC is -$0.48
What is the all time high quarterly EPS for Benitec Biopharma?
Benitec Biopharma all-time high quarterly earnings per share is $15.56
What is Benitec Biopharma quarterly EPS year-on-year change?
Over the past year, BNTC quarterly earnings per share has changed by +$2.16 (+81.82%)
What is Benitec Biopharma TTM earnings per share?
The current TTM EPS of BNTC is -$5.29
What is the all time high TTM EPS for Benitec Biopharma?
Benitec Biopharma all-time high TTM earnings per share is $7.68
What is Benitec Biopharma TTM EPS year-on-year change?
Over the past year, BNTC TTM earnings per share has changed by +$5.72 (+51.96%)